AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
AstraZeneca has set up a research deal with Seres Therapeutics, agreeing to pay the biotech $20 million in installment payments for their collaboration on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
